NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. (“Lev” or the “Company”) (OTCBB:LEVP) today announced it entered into a $20 million senior secured term loan facility with Mast Capital Management for the financing of additional plasma purchases.
NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. (“Lev” or the “Company”) (OTCBB:LEVP) today announced it entered into a $20 million senior secured term loan facility with Mast Capital Management for the financing of additional plasma purchases.
